Analysis for the Resistance Collaborative Group

First Page		Document Content
Date: 1999-10-29 04:20:04 Protease inhibitors Organofluorides Amides Cyclopropanes Antiretroviral drug Viral load HIV Reverse-transcriptase inhibitor Efavirenz Chemistry Organic chemistry HIV/AIDS		Analysis for the Resistance Collaborative Group Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 937,58 KB Share Document on Facebook

	AIDS InfoNetwww.aidsinfonet.org Fact Sheet Number 125 VIRAL LOAD TESTS WHAT IS VIRAL LOAD? DocID: 1uGdt - View Document
	Expanding HAART to Stop HIV & AIDS Julio Montaner MD, FRCPC, FCCP Director, BC-Centre for Excellence on HIV/AIDS, Providence Health Care Professor of Medicine and Chair, AIDS Research, University of British Columbia Pres DocID: 1qebk - View Document
	DISEASES OF AQUATIC ORGANISMS Dis Aquat Org Vol. 84: 89–94, 2009 doi: dao02036 DocID: 1pi5g - View Document
	Tata Medical Center, Kolkata: Virology Services A. CMV viral load: Rsa. EDTA whole blood samples in purple top BD vacutainer b. TAT: max. 8 days (test done every Thursday) c. Participates in UK NEQAS and uses WHO- DocID: 1o10O - View Document
	R esearch A rticle Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics Background: Dried blood spot (DBS) sampling is emerging as a valuable technique in a DocID: 1njya - View Document